Immunogenicity and safety of the quadrivalent inactivated split-virion influenza vaccine in populations aged ≥ 3 years: A phase 3, randomized, double-blind, non-inferiority clinical trial

• Main Authors: Jianmin Chen (Author), Feng Jiang (Author), Chenyan Zhao (Author), Jing Chai (Author), Lanshu Li (Author), Qinghu Guan (Author), Xiaoyu Li (Author), Feiyu Wang (Author), Ansheng Li (Author), Hongxia Gao (Author), Minghui Wang (Author), Liandi Fu (Author), Fei Nie (Author), Weijun Ling (Author), Haobin Deng (Author), Lei Zhou (Author)
• Format: Book
• Published: Taylor & Francis Group, 2023-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

This study aimed to evaluate the immunogenicity non-inferiority and safety of the quadrivalent inactivated split-virion influenza vaccine in participants ≥ 3 years old. A total of 3,328 participants were enrolled. Participants 3-8 years old were administered one or two doses of the investigational v...